DDInter1311 DDInter1082
Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic.
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Norepinephrine {u} (Compound) resembles {v} (Compound) Methyldopa
Norepinephrine {u} (Compound) resembles {v} (Compound) Epinephrine
Norepinephrine {u} (Compound) binds {v} (Gene) ADRA1D
Norepinephrine {u} (Compound) upregulates {v} (Gene) MCOLN1
Norepinephrine {u} (Compound) is included by {v} (Pharmacologic Class) Catecholamines
Norepinephrine {u} (Compound) causes {v} (Side Effect) Violent
Norepinephrine (Compound) resembles Methyldopa (Compound)
Norepinephrine (Compound) resembles Epinephrine (Compound)
Norepinephrine (Compound) binds ADRA1D (Gene)
Norepinephrine (Compound) upregulates MCOLN1 (Gene)
Norepinephrine (Compound) is included by Catecholamines (Pharmacologic Class)
Norepinephrine (Compound) causes Violent (Side Effect)